Ethyl (3S,4aR,6S,8aR)-6-(4-ethoxycarbonylimidazol-1-ylmethyl)decahydroiso-quinoline-3-carboxylic ester:: A prodrug of a GluR5 kainate receptor antagonist active in two animal models of acute migraine

被引：46

作者：

Filla, SA ^{[1
]}

Winter, MA

Johnson, KW

Bleakman, D

Bell, MG

Bleisch, TJ

Castaño, AM

Clemens-Smith, A

del Prado, M

Dieckman, DK

Dominguez, E

Escribano, A

Ho, KH

Hudziak, KJ

Katofiasc, MA

Martinez-Perez, JA

Mateo, A

Mathes, BM

Mattiuz, EL

Ogden, AML

Phebus, LA

Stack, DR

Stratford, RE

Ornstein, PL

机构：

[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA

[2] Ctr Invest Lilly, Madrid 28108, Spain

[3] Allelix Biopharmaceut, Mississauga, ON L4V 1P1, Canada

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2002年 / 45卷 / 20期

关键词：

D O I：

10.1021/jm025548q

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Amino diacid 3, a highly selective competitive GluR5 kainate receptor antagonist, exhibited high GluR5 receptor affinity and selectivity over other glutamate receptors. Its diethyl ester prodrug 4 was orally active in two models of migraine: the neurogenic dural plasma protein extravasation model and the nucleus caudalis c-fos expression model. These data suggest that a GluR5 kainate receptor antagonist might be an efficacious antimigraine therapy with a novel mechanism of action.

引用

页码：4383 / 4386

页数：4

共 38 条

[1] THE PRIMARY AFFERENT DEPOLARIZING ACTION OF KAINATE IN THE RAT
AGRAWAL, SG
EVANS, RH
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 1986, 87 (02) : 345 - 355
[2] Plasma levels of neuroexcitatory amino acids in patients with migraine or tension headache
Alam, Z
Coombes, N
Waring, RH
Williams, AC
Steventon, GB
[J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 156 (01) : 102 - 106
[3] BEMIS KG, 1985, AM STAT ASS BIOPH P, P72
[4] Pharmacological characterization of a GluR6 kainate receptor in cultured hippocampal neurons
Bleakman, D
Ogden, AM
Ornstein, PL
Hoo, K
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 378 (03) : 331 - 337
[5] Neuropharmacology of AMPA and kainate receptors
Bleakman, D
Lodge, D
[J]. NEUROPHARMACOLOGY, 1998, 37 (10-11) : 1187 - 1204
[6] Bleakman D, 1996, MOL PHARMACOL, V49, P581
[7] Structure-activity studies of aryl-spaced decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists
Bleisch, TJ
Ornstein, PL
Allen, NK
Wright, RA
Lodge, D
Schoepp, DD
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (09) : 1161 - 1166
[8] NEUROGENIC MODEL OF MIGRAINE
BUZZI, MG
BONAMINI, M
MOSKOWITZ, MA
[J]. CEPHALALGIA, 1995, 15 (04) : 277 - 280
[9] THE ANTIMIGRAINE DRUG, SUMATRIPTAN (GR43175), SELECTIVELY BLOCKS NEUROGENIC PLASMA EXTRAVASATION FROM BLOOD-VESSELS IN DURA MATER
BUZZI, MG
MOSKOWITZ, MA
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 1990, 99 (01) : 202 - 206
[10] COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143

← 1 2 3 4 →